Search results
Shark Tank Judge Namita Thapar To Earn Rs 127 Crore From Emcure IPO
NDTV· 6 days agoNamita Thapar, the Executive Director of Emcure Pharmaceuticals, is set to earn approximately Rs...
Emcure Pharmaceuticals IPO last bidding date today. Should you subscribe? Check GMP, subscription...
Livemint· 4 days agoEmcure Pharmaceuticals IPO aims to utilise funds to reduce long-term debt and focus on important...
Emcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or...
Livemint· 6 days agoEmcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price...
Emcure Pharmaceuticals IPO: Issue booked 4.98 times on the second bidding day. Check latest GMP,...
Livemint· 4 days agoEmcure Pharmaceuticals IPO subscription status: Emcure Pharmaceuticals, backed by Bain Capital,...
Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely to earn ₹127 crore - CNBC TV18
CNBC TV18· 6 days agoThe initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on...
Emcure Pharmaceuticals IPO opens today | India Infoline
India Infoline· 5 days agoThe IPO, backed by Bain Capital, has a price band set between ₹960 and ₹1,008 per share and will close on July 5.
Emcure Pharmaceuticals' IPO subscription closes today | India Infoline
India Infoline· 3 days agoOn the third day of bidding, at the time of writing on July 5, 2024 at 12:12 pm, Emcure Pharmaceuticals IPO is witnessing a overall subscription of 8.83 times.
Emcure Pharmaceuticals IPO Day 2: From key risks to financials, here are 10 things to know from RHP...
Livemint· 4 days agoEmcure Pharmaceuticals IPO saw positive investor response with overwhelming demand, offering new...